Skip to content
Screener

Surgery Partners, Inc. SGRY Common stock, par value (in dollars per share)

Common stock, par value (in dollars per share) at other companies

UnitedHealth Group logo
UnitedHealth GroupUNH
$0.010.0%
ARD
Ardent Health PartnersARDT
$0.010.0%
Solventum logo
SolventumSOLV
$0.010.0%
Stryker logo
StrykerSYK
$0.100.0%
Tenet Healthcare logo
Tenet HealthcareTHC
CONMED logo
CONMEDCNMD

Other financials

Income statement

See full
Revenue$848.9M+2.7%
Operating income$102.1M-8.6%
Net income-$15.0M-500%
EPS (diluted)-$0.12-500%

Balance sheet

See full
Cash & equivalents$216.7M-13.4%
Total debt$5.1B+3.9%
Total equity$1.7B-4.4%
Total assets$8.0B+1.2%

Cash flow

See full
Operating cash flow$59.3M-27.1%
CapEx$21.8M-6.8%
Free cash flow$37.5M-35.2%

Valuation

See full
Market cap$2.03B-30.3%
Enterprise value$6.89B-8.7%
P/S0.6×-0.3×

Profitability

See full
Gross margin23.1%
Operating margin11.4%+0.2pp
Net margin-2.6%-0.9pp
FCF margin5.6%+0.2pp

Returns & leverage

See full
Return on equity-5.2%-1.7pp
Debt / equity+0.2×
Current ratio1.9×0.0×

Where this comes from

Reported directly by Surgery Partners, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.

The source filing: Surgery Partners, Inc.’s 10-Q, filed August 10, 2026.

Filed
Aug 10, 2026, 4:14 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001638833-26-000077
Line item(Unaudited) / June 30, 2026December 31, 2025
Non-controlling interests—redeemable366.7395.5
Stockholders' equity:
Preferred stock, $0.01 par value; shares authorized - 20,310,000; shares issued or outstanding - none
Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 130,886,397 and 129,321,144, respectively1.31.3
Additional paid-in capital2,544.42,540.6
Accumulated other comprehensive income (loss)(8.9)(13.8)
Retained deficit(866.1)(815.2)
Total Surgery Partners, Inc. stockholders' equity1,670.71,712.9

Item 1. Financial Statements

FAQ

What is Surgery Partners, Inc.'s common stock, par value (in dollars per share)?
Surgery Partners, Inc. (SGRY) reported common stock, par value (in dollars per share) of $0.01 in Q2 2026.
How has Surgery Partners, Inc.'s common stock, par value (in dollars per share) changed year-over-year?
Surgery Partners, Inc.'s common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0.01 to $0.01.
What is the long-term trend for Surgery Partners, Inc.'s common stock, par value (in dollars per share)?
Over 5 years (2020 to 2025), Surgery Partners, Inc.'s common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0.01 to $0.01.
What does common stock, par value (in dollars per share) mean?
Common stock, par value (in dollars per share)

Ask your AI about Surgery Partners, Inc.'s common stock, par value (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude